Changes in drug use and out-of-pocket costs associated with medicare part D implementation: A systematic review

Journal of the American Geriatrics Society

Volumn 58, Issue 9, 2010, Pages 1764-1779

  Polinski, Jennifer M ^a,b   Kilabuk, Elaine ^c   Schneeweiss, Sebastian ^a,b   Brennan, Troyen ^d   Shrank, William H ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD UNIVERSITY   (United States)

^d CVS Caremark   (United States)

Author keywords

drug utilization; Medicare Part D; out of pocket costs; systematic review

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTILIPEMIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; ORAL ANTIDIABETIC AGENT; PROTON PUMP INHIBITOR; WARFARIN;

COMORBIDITY; DRUG COST; DRUG USE; DRUG UTILIZATION; HEALTH CARE COST; HUMAN; LONG TERM CARE; MEDICARE; PRESCRIPTION; REVIEW; COST OF ILLNESS; ECONOMICS; INSURANCE; TRENDS; UNITED STATES;

COST OF ILLNESS; DRUG COSTS; DRUG PRESCRIPTIONS; DRUG UTILIZATION; HUMANS; INSURANCE COVERAGE; MEDICARE PART D; UNITED STATES;

EID: 77956306395     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.03025.x     Document Type: Review

References (31)

1. United States Congress. Medicare prescription drug, improvement and modernization act of 2003 Public Law 108-173. Available at Accessed October 7, 2008.
2. Wells G, Shea B, O'Connell D et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Paper presented at: Proceedings of the 3rd Symposium on Systematic Reviews. Beyond the basics: Improving quality and impact, 2000; Oxford.
3. Ketcham JD, Simon KI. Medicare Part D's effects on elderly patients' drug costs and utilization. Am J Manag Care 2008 14 (11 Suppl) : SP14 SP22.
4. Lichtenberg FR, Sun SX. The impact of Medicare Part D on prescription drug use by the elderly. Health Aff 2007 26 : 1735 1744.
5. Yin W, Basu A, Zhang JX et al. The effect of the Medicare Part D prescription benefit on drug utilization and expenditures.[see comment][summary for patients in Ann Intern Med 2008; 148:I14; PMID: 18180464]. Ann Intern Med 2008 148 : 169 177.
6. Chen H, Nwangwu A, Aparasu R et al. The impact of Medicare Part D on psychotropic utilization and financial burden for community-based seniors. Psych Serv 2008 59 : 1191 1197.
7. Joyce GF, Goldman DP, Vogt WB et al. Medicare Part D after 2 years. Am J Manag Care 2009 15 : 536 544.
8. Schneeweiss S, Patrick AR, Pedan A et al. The effect of Medicare Part D drug coverage on drug use and cost-sharing in seniors without prior drug benefits. Health Aff 2009 28 : 305 316.
9. Zhang JX, Yin W, Sun SX et al. The impact of the Medicare Part D prescription benefit on generic drug use. J Gen Intern Med 2008 23 : 1673 1678.
10. Zhang Y, Donohue JM, Lave JR et al. The effect of Medicare Part D on drug and medical spending. N Engl J Med 2009 361 : 52 61.
11. Briesacher BA, Soumerai SB, Field TS et al. Nursing home residents and enrollment in Medicare Part D. J Am Geriatr Soc 2009 57 : 1902 1907.
12. Kim MH, Lin J, Kreilick C National assessment of Medicare prescription plan coverage gaps among patients with atrial fibrillation in the US. Adv Ther 2009 26 : 784 794.
13. Madden JM, Graves AJ, Ross-Degnan D et al. Cost-related medication nonadherence after implementation of Medicare Part D, 2006-2007. JAMA 2009 302 : 1755 1756.
14. Madden JM, Graves AJ, Zhang F et al. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA 2008 299 : 1922 1928.
15. Schmittdiel JA, Ettner SL, Fung V et al. Medicare Part D coverage gap and diabetes beneficiaries. Am J Manag Care 2009 15 : 189 193.
16. Basu A, Yin W, Alexander GC. The impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries' prescription utilization and expenditures. National Bureau of Economic Research Working Paper Series; 2008.
17. Das-Douglas M, Riley ED, Ragland K et al. Implementation of the Medicare Part D prescription drug benefit is associated with antiretroviral therapy interruptions. AIDS Behav 2009 13 : 1 9.
18. Golden A, Roos BA, Beers MH. The unintended outcome of a supplemental formulary in homebound seniors. J Am Geriatr Soc 2009 57 : 927 929.
19. Hall JP, Kurth NK, Moore JM. Transition to Medicare Part D: An early snapshot of barriers experienced by younger dual eligibles with disabilities. Am J Manag Care 2007 13 : 14 18.
20. Huskamp HA, West JC, Rae DS et al. Part D and dually eligible patients with mental illness: Medication access problems and use of intensive services. Psych Serv 2009 60 : 1169 1174.
21. Shrank WH, Patrick AR, Pedan A et al. The effect of transitioning to Medicare Part D drug coverage in seniors dually eligible for Medicare and Medicaid. J Am Geriatr Soc 2008 56 : 2304 2310.
22. West JC, Wilk JE, Muszynski IL et al. Medication access and continuity: The experiences of dual-eligible psychiatric patients during the first 4 months of the Medicare prescription drug benefit [see comment]. Am J Psychiatr 2007 164 : 789 796.
23. Cronk A, Humphries TL, Delate T et al. Medication strategies used by Medicare beneficiaries who reach the Part D standard drug-benefit threshold. Am J Health Syst Pharm 2008 65 : 1062 1070.
24. Hsu J, Fung V, Price M et al. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs. JAMA 2008 299 : 1929 1936.
25. Pedan A, Lu J, Varasteh LT. Assessment of drug consumption patterns for Medicare Part D patients. Am J Manag Care 2009 15 : 323 327.
26. Raebel MA, Delate T, Ellis JL et al. Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare Part D. Med Care 2008 46 : 1116 1122.
27. Sun SX, Lee KY. The Medicare Part D doughnut hole: Effect on pharmacy utilization. Manag Care Interface 2007 20 : 51 55.
28. Zhang Y, Donohue JM, Newhouse JP et al. The effects of the coverage gap on drug spending: A closer look at Medicare Part D. Health Aff 2009 28 : 317 325.
29. U.S. Government Accountability Office. Report to Congressional requesters: Medicare Part D, Challenges in enrolling new dual-eligible beneficiaries. Available at Accessed December 3, 2009.
30. Soumerai SB, Ross-Degnan D et al. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med 1991 325 : 1072 1077.
31. Polinski J, Schneeweiss S, Levin R et al. Completeness of retail pharmacy claims data: Implications for pharmacoepidemiologic studies and pharmacy practice in older adults. Clin Ther 2009 31 : 2048 2059.